Hello! You're looking at a policy document report on Overton
We track government policy, guidelines, think tank research, working papers and more to help our customers see the impact and influence of their work. Are you interested in seeing what information we have to offer? Request a free trial to our platform.
If you fund, produce or manage research or work to influence policy, we'd love to talk. Learn more on our homepage.
Risk assessment: Outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): increased transmission beyond China fourth update
European Centre for Disease Prevention and Control on
February 15th 2020
On 31 December 2019, a cluster of pneumonia cases of unknown aetiology was reported in Wuhan, Hubei Province, China. On 9 January 2020, China CDC reported a novel coronavirus as the causative agent of this outbreak, which is phylogenetically in the SARS-CoV clade. The novel coronavirus has thus been named ‘severe acute respiratory syndrome coronavirus 2’ (SARS-CoV-2), while coronavirus disease associated with it is now referred to as COVID-19.
Topics in this document
Medical humanities
Epidemiology
Health sciences
Clinical medicine
Medical specialties
Medicine
Personal protective equipment
Severe acute respiratory syndrome coronavirus 2
Social distancing
Infection
Severe acute respiratory syndrome
Middle East respiratory syndrome-related coronavirus
Severe acute respiratory syndrome coronavirus
Influenza
Transmission (medicine)
Surgical mask
Coronavirus
Health care
Infection control
Severe acute respiratory syndrome-related coronavirus
Public health
Health professional
Risk
Emergency management
Health
Diseases and disorders
European Centre for Disease Prevention and Control
Disease
Screening (medicine)
Virus
Related SDGs
Cites research funded by
3
MRC
1
National Key R&D Program of China
1
Government of the Hong Kong Special Administrative Region
1
Joint Fund of Coal
1
the Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences
1
National Science and Technology Major Project of China
1
China-US Collaborative Program on Emerging and Re-emerging Infectious Disease
1
National Science Fund for Distinguished Young Scholars
1
Terumo
1
Terumo BCT
2
NIHR (October 2023)
2
NIHR (September 2022)
1
FP7_REST_ALL (Special project, May 2022)
1
FP7_REST_SecondPillar (Special project, May 2022)
1
Swiss National Science Foundation
1
Wellcome Trust
1
National Institute for Health Research (NIHR)
1
Medical Research Council
1
Bill & Melinda Gates Foundation
1
Economic and Social Research Council
1
ESRC January 2022
1
ESRC
Citations
Cited by 17 other policy documents
(12 of them are from other policy sources)